Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Native is an AI-native company focused on enabling capital, talent, and technology to build the artificial intelligence industry. It is not involved in drug discovery or healthcare product development. The company operates accelerator programs such as GAIA to support early-stage generative AI startups and aims to foster the growth of the global AI ecosystem—especially in emerging markets like MENA—by providing resources and mentorship for founders. New Native Inc does not operate within the life science/biotech/pharma/healthcare sector. It focuses exclusively on building infrastructure for the artificial intelligence industry by running accelerators like GAIA that support early-stage generative AI companies—primarily outside of health-related fields at this time.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Native.